Skip to content

The Efficacy of Chewing Gums Versus Laxative in Early Return of Bowel Function After CS

The Efficacy of Chewing Gums Versus Laxatives in Early Return of Bowel Function After Cesarean Section

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02765971
Enrollment
540
Registered
2016-05-09
Start date
2016-05-31
Completion date
2019-10-31
Last updated
2019-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal Recovery After Cesarean Section

Keywords

chewing gums, laxatives, bowel function

Brief summary

540 consented women for being enrolled in this clinical trial and candidates for elective cesarean section will be divided into 3 groups: * Group A, 180 women will receive sugarless gum after their operating room discharge by 3 hours for at least half an hour at two hours interval. * Group B, 180 women will receive laxatives after their operating room discharge by 3 hours. * Group C, 180 women as control group, they will not receive neither gum nor oral fluids. They will be on intravenous fluid. starting oral fluids after hearing intestinal sounds .

Detailed description

540 consented women for being enrolled in this clinical trial and candidates for elective cesarean section will be divided into 3 groups: * Group A, 180 women will receive sugarless gum after their operating room discharge by 3 hours for at least half an hour at two hours interval. * Group B, 180 women will receive laxatives after their operating room discharge by 3 hours. Group C, 180 women as control group, they will not receive neither gum nor oral fluids. They will be on intravenous fluid. starting oral fluids after hearing intestinal sounds .

Interventions

OTHERgums

Group A, 180 women will receive sugarless gum after their operating room discharge by 3 hours for at least half an hour at two hours interval.

DRUGpicolax drops

Group B, 180 women will receive laxatives after their operating room discharge by 3 hours.

DRUGnormal saline

Group C received 500 cc of normal saline, Intravenous fluid

Sponsors

Ahmed M Maged, MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* all women undergoing elective cesarean section in Kasr Al AI Aini hospital will be candidate for this trial after full explanation of the trial and informed consent to be taken from the women.

Exclusion criteria

* cesarean hysterectomy, * surgical management of severe postpartum hemorrhage * previous bowel surgery * women with history of drug consumption,especially opioids * water and electrolyte disturbances * pancreatitis or peritonitis * inability to chew gum * diabetes, pregnancies accompanied by coagulopathy like pre-eclampsia, hypothyroidism, muscular and neurological disorders * postoperative admission to intensive care unit * history of abdominal surgery except cesarean section * history of postoperative ileus * patients with drains

Design outcomes

Primary

MeasureTime frame
appearance of intestinal sounds postoperative evaluated by stethoscope4-6 hours after CS

Countries

Egypt

Contacts

Primary ContactAhmed Maged
dr_ahmedmaged@kasralainy.edu.eg0020201005227404
Backup ContactAsmaa Ogila
drasmaaibrahim@hotmail.com+20201001936908

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026